학술논문

Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma
Document Type
Journal
Source
EUROPEAN RESPIRATORY JOURNAL; SEP 28 2019, 54 2p. Supplement: 63
Subject
Language
English
ISSN
13993003